On 22 December 2015, the Journal of Neurology and Neuroscience published commentary by Emeritus Professor Bernhard HJ Juurlink, College of Medicine, University of Saskatchewan, Canada, titled ''Time to Revisit Non-Pharmacological Research Approaches to Ameliorate Multiple Sclerosis Symptoms'' which he introduced as follows
''There is an abundance of evidence that MS is not primarily an autoimmune disease but is a disease where there is first damage to the blood-brain barrier as well as the oligodendrocyte-myelin unit; this damage then elicits an immune response in a subset of people that have an immune system predisposed to attacking myelin-associated antigens''
He went on to provide a brief overview of the evidence for arterial compliance problems, intracranial compliance problems, venous return problems and hypoperfusion problems in MS. Professor Juurlink's summations need to be read in parallel with the outcomes of Dr Bavera's long term follow up of multiple sclerosis patients treated with PTA for diagnosed CCSVI conditions. Following are details of many of the historical backgrounds also associated with Professor Juurlink's summations.

It is being consistently shown that the proper treatment of this vascular condition, by long standing, safe and minimally invasive medical interventions, can result in dramatic (and at times immediate) improvements in many of the most common symptoms of multiple sclerosis. What is being learnt is no…